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Letter to the Editor
o the Editor:
I read with great interest your article
"Evaluation of the strep B OIA test compared to
standard culture methods for detection of group B
streptococci" in Infectious Diseases in Obstetrics
and Gynecology (1999;7:202-205). It is worth men-
tioning that we performed a similar study (unpub-
lished) at Grace Hospital (Wayne State University
School of Medicine, Detroit Medical Center, De-
troit, Michigan), in 1995, in collaboration with B.
Gonik, MD. Partial results of that study were pre-
sented at the annual meeting of IDSOG in Grand
Traverse Village, Michigan, in August, 1995.1
Our study was divided into two phases. During
the first phase, the rapid test was performed both
in Labor and Delivery and in the laboratory. Dur-
ing the second phase the study was performed only
in the laboratory. Results of the culture for (GBS)
were reported semiquantitatively as containing 1+
(rare), 2+ (few), 3+ (moderate), or 4+ (numerous)
colonies in the blood-agar broth, when 1-10, 11-20,
21-30, and ->31 GBS colonies, respectively, were
counted; as positive in Todd Hewitt broth only; or
as negative. The total results, which includes first
and second phases (n 256 women), are presented
in Table 1. There were 53 positive cultures among
256 cases (20.7%). There were 22 positive cultures
among 117 cases (18.8%) in the first phase of the
study (11/22 positive cultures in THB only) and 31
TABLE I. Biostar OIA and culture results for GBS
intrapartum detection: laboratory first and second
phases (n 256)
No Broth only Blood agar
growth (THB) +1 +2 +3 +4 Total
KIT 3 0 2 18
KIT- 202 23 8 0 4 238
Total 203 26 8 6 12 256
aSensitivity 32. I, specificity 99.5, positive predictive value 94.4, negative
predictive value 84.9.
positive cultures among 139 cases (22.3%) in the
second phase (15/31 positive cultures in THB
only). The sensitivity, specificity, positive predic-
tive value (PPV), and negative predictive value
(NPV) for L&D and laboratory in the first phase of
the study were 31.8, 91.5, 46.7, and 85.3 and 27.3,
100, 100, and 85.6, respectively. In the second
phase of the study the sensitivity improved to
35.5%, and the overall sensitivity, specificity, PPV,
and NPV for the two phases of the study were 32.1,
99.5, 94.4, and 84.9%, respectively.
The OIA (Biostar) test was found to be very
easy to perform, the result being obtained after 30
min. Nevertheless, during the first phase of the
study, an unacceptable false-positive rate in L&D
indicated technical difficulties in the running and
interpretation of the test that were not found in the
laboratory-performed tests. In the second phase of
the study sensitivity was improved.
Our results showed that, although the OIA (Bio-
star) test is easy to perform, better results are
obtained when it is performed by experienced
laboratory personnel. The test lacks adequate sen-
sitivity in women with low and moderate GBS colo-
nization. It should be concluded that the ideal
rapid test for the diagnosis of GBS intrapartum
colonization is still to be developed.
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